ENDEFR
Home › France › PIERRE FABRE MEDICAMENT

PIERRE FABRE MEDICAMENT

société par actions simplifiée (SAS) · LAVAUR, France · LEI 969500ROQWSNEW8T9489
LEI active

Summary

PIERRE FABRE MEDICAMENT is registered in France and entered in the “Sirene business register (INSEE)” under number 326118502. Its legal form is société par actions simplifiée (SAS) – simplified joint-stock company (France). According to GLEIF, its ultimate parent is PIERRE FABRE PARTICIPATIONS (France), and its direct parent is PIERRE FABRE SA (France). That group has 6 subsidiaries with LEIs in 2 countries, 5 of them in France. It has 2 direct subsidiaries in GLEIF data. The LEI was first issued on 27 Jan 2014 and the record was last updated on 21 Oct 2025; the next renewal is due by 21 Nov 2026.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formsociété par actions simplifiée (SAS)
simplified joint-stock company (France)
RegisterSirene business register (INSEE) · Register website
Registration number326118502
Registration authorityNational Institute of Statistics and Economic Studies
JurisdictionFrance
Registered addressCAUQUILLOUS BAS, 81500 LAVAUR, France
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)27 Dec 1982
LEI969500ROQWSNEW8T9489
LEI statusactive
LEI first issued27 Jan 2014
LEI record last updated21 Oct 2025
Next LEI renewal21 Nov 2026
Corroboration of the LEI recordfully corroborated

Group membership

PIERRE FABRE PARTICIPATIONS France lapsed ultimate parent
PIERRE FABRE SA France direct parent
PIERRE FABRE MEDICAMENT this entity
INSTITUT DE RECHERCHE PIERRE FABRE France
PIERRE FABRE MEDICAMENT PRODUCTION France
View the whole group: 6 subsidiaries in 2 countries

Relationship to the parent

Direct parentUltimate parent
ParentPIERRE FABRE SAPIERRE FABRE PARTICIPATIONS
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidenceother official documentsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Accounting standardother standardIFRS
Relationship start1 Jan 20241 Jan 2024
Recorded at GLEIF since20 Nov 201720 Nov 2017
Last updated19 May 202619 May 2026
Record statuscurrentcurrent

Direct subsidiaries (2)

Other subsidiaries of the same direct parent (1)

Other names

  • LABO ROBOPHARM-PIERRE FABRE PHARMACEUTIC · trading name